GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pulsion Medical Systems SE (LTS:0NFX) » Definitions » Cash Conversion Cycle

Pulsion Medical Systems SE (LTS:0NFX) Cash Conversion Cycle : 56.65 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Pulsion Medical Systems SE Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Pulsion Medical Systems SE's Days Sales Outstanding for the six months ended in Dec. 2023 was 4.04.
Pulsion Medical Systems SE's Days Inventory for the six months ended in Dec. 2023 was 84.87.
Pulsion Medical Systems SE's Days Payable for the six months ended in Dec. 2023 was 32.26.
Therefore, Pulsion Medical Systems SE's Cash Conversion Cycle (CCC) for the six months ended in Dec. 2023 was 56.65.


Pulsion Medical Systems SE Cash Conversion Cycle Historical Data

The historical data trend for Pulsion Medical Systems SE's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pulsion Medical Systems SE Cash Conversion Cycle Chart

Pulsion Medical Systems SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.25 122.63 123.75 119.73 56.65

Pulsion Medical Systems SE Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 161.25 122.63 123.75 119.73 56.65

Competitive Comparison of Pulsion Medical Systems SE's Cash Conversion Cycle

For the Medical Devices subindustry, Pulsion Medical Systems SE's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pulsion Medical Systems SE's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pulsion Medical Systems SE's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Pulsion Medical Systems SE's Cash Conversion Cycle falls into.



Pulsion Medical Systems SE Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Pulsion Medical Systems SE's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=4.04+84.87-32.26
=56.65

Pulsion Medical Systems SE's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=4.04+84.87-32.26
=56.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pulsion Medical Systems SE  (LTS:0NFX) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Pulsion Medical Systems SE Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Pulsion Medical Systems SE's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Pulsion Medical Systems SE Business Description

Traded in Other Exchanges
N/A
Address
Hans-Riedl-Street 17, Feldkirchen, DEU, 85622
Pulsion Medical Systems SE operates with its business units hemodynamic monitoring which is engaged in developing, manufacturing, and sale of systems used to monitor, diagnose, and manage physical parameters of patients in intensive care unit, and perfusion imaging which is engaged in developing, manufacturing, and sale of indocyanine green and complementary devices to visualize micro perfusion. The technology developed by the company for critical care are picco, proaqt, limon technology, and eirus technology.

Pulsion Medical Systems SE Headlines

No Headlines